Amir Adel Rashidi, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

A systematic review of risk-benefit analytic methods applied in health care
Canadian Journal of Clinical Pharmacology
12i(1):46
Date: 01 2005

The cost-effectiveness of adding infliximab to usual therapy in the treatment of psoriatic arthritis
Value in Health
8(3):237-419
Date: 03 2005

Are Indirect Utility Measures Reliable and Responsive in Rheumatoid Arthritis Patients?
Quality of Life Research
14(5):1333-1344
Date: 05 2005

When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions
Medical Association Journal
173(11):1335-1340
Date: 11 2005

Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients
Health and Quality of Life Outcomes
20; 4:25
Date: 04 2006

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone
J Clin Endocrinol Metab
92(7):2590-7
Date: 07 2007

Impact of Family History of Diabetes and Ethnicity on beta-cell Function in Obese, Glucose-Tolerant Individuals.
J Clin Endocrinol Metab
92(12):4656-63
Date: 12 2007